Username Password
S&P 500: 2,053.42
Change: +0.08%

EXELIXIS INC. (EXEL)

Overview
Price 1.73
Price Change Today +$0.10 (+6.13%)
P&P rating Rating: 3
Open Price $1.63
Previous Close $1.63
Daily Range $1.61 - $1.73
52-Week Range $1.26 - $7.64
Volume 697
chart
Top Buy Analysis
BUY: EXEL Rating: 3
Company: EXELIXIS INC.
Points: -122.70
Start Price: $5.57
Start Date: 06/11/2008 6:52 PM
GreedsGood
GreedsGood
P&P Score: 62.83
Recs:
Undervalued

Comments: 0 | Comment

Top Sell Analysis
SELL: EXEL Rating: 3
Company: EXELIXIS INC.
Points: 142.99
Start Price: $9.35
Start Date: 06/19/2011 9:24 AM
Hqdepot
Hqdepot
P&P Score: 51.71
Recs:
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

28 Buy
1 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 03/10/10 Zantrio.com Free Daily Stock Picks 3-10-2010 0
zantriocom
0.00 11/09/09 Zantrio.com Free Daily Stock Picks 11-9-09 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 12/20/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Zacks_Analysts
0.00 07/26/10 Sanofi Launches Cancer Treatment - Analyst Blog 0
Zacks_Analysts
0.00 06/30/10 Sanofi to Acquire TargaGen - Analyst Blog 0
Zacks_Analysts
0.00 06/22/10 BMY Terminates EXEL Partnership - Analyst Blog 0
Zacks_Analysts
0.00 06/18/10 FDA Approves Sanofi Drug - Analyst Blog 0
Zacks_Analysts
0.00 06/07/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Pages: [ 1 ]  2  >>
Commentary
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -88.14
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
SELL: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $9.35
Points: +142.99
Created: 06/19/2011
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $12.35
Points: -138.41
Created: 04/26/2011
Ready to break out of weekly and monthly charts plus close to breaking out of short term consolidation

Comments: 1 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $7.21
Points: -141.39
Created: 12/14/2010
promising medicin

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $5.57
Points: -122.70
Created: 06/11/2008
Undervalued

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $6.50
Points: -122.49
Created: 06/04/2008
Phase 2 and 3's are coming!!!! 500% gain in 5 years if not more.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $5.57
Points: -138.66
Created: 10/19/2011
buy

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.33
Points: -135.59
Created: 10/12/2010

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $3.58
Points: -151.41
Created: 07/06/2010

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $7.20
Points: -115.85
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
BriansLongshots 1.37 BUY Three Plus Years 05/23/2013 $4.77 $1.73
(+6.13%)
-63.73% +24.41% -88.14 view
rtezanos 0.92 BUY Week or Less 10/19/2011 $5.57 $1.73
(+6.13%)
-68.94% +69.72% -138.66 view
Hqdepot 51.71 SELL Six Months to a Year 06/19/2011 $9.35 $1.73
(+6.13%)
-81.50% +61.50% +142.99 view
wallstreeter 14.30 BUY Six Months to a Year 04/26/2011 $12.35 $1.73
(+6.13%)
-85.99% +52.42% -138.41 view
cmmtgnmn 51.71 BUY Six Months to a Year 12/14/2010 $7.21 $1.73
(+6.13%)
-76.01% +65.39% -141.39 view
EyePhone 63.08 BUY One to Three Months 10/12/2010 $4.33 $1.73
(+6.13%)
-60.05% +75.54% -135.59
HardTimes 65.39 BUY One to Three Months 07/06/2010 $3.58 $1.73
(+6.13%)
-51.68% +99.74% -151.41
GreedsGood 62.83 BUY One to Three Years 06/11/2008 $5.57 $1.73
(+6.13%)
-68.94% +53.76% -122.70 view
POTASHKing 12.02 BUY Three Plus Years 06/04/2008 $6.50 $1.73
(+6.13%)
-73.38% +49.10% -122.49 view
Dave Brushart 95.45 BUY Six Months to a Year 01/01/2008 $7.20 $1.73
(+6.13%)
-75.97% +39.88% -115.85
Pages: [ 1 ]  2   3  >>
Sponsored Links